PHARMA LITERATI

Global pharmaceutical sales are predicted to reach $1567.80 billion by 2023 and based on the launch of new technologies and the approval of the first cell and gene therapies the estimate in prescription drug sales in is $1.18 trillion.In addition, China’s biopharmaceutical sales grew almost 25% annually from $9.4 billion from 2012 to 2016 and if it continues to grow at the expected rate, the sales volume will be $48.8 billion by 2021. Here are six pharmacy and retail trends to expect in 2020. 1. 360 degree supply chain “Today, the supply chain has evolved into a critical component of a company’s ability to satisfy customers, drive profitable growth and deliver new innovations to the market.” Allan Dow, president of Logility. Having a 360 degree supply chain will be the way forward for retailers to lower prices and open up a channel of dialogue with suppliers - showing the process from initial materials used to the end product delivery. German pharm...

What does 2019 have in store for Pharma? It was asked to industry Thought Leaders to name one disruptive trend or technology that will have a significant impact on the market in the year ahead. Will pricing pressure lead to a shift in budget management? Is this the year for biosimilar approvals? Will we see continued M&A activity in the sector? From life cycle management to AI, and Supergenerics to digital healthcare, listed are the Pharma and Biopharma trends about 2019. 1. Big Pharma Restructuring will Create Challenges and Opportunities Jim Miller, Former President & Founder, PharmSource 2. Continued M&A in the CDMO and CMO Business Sector Kevin Bottomley, Partner, Results Healthcare 3. 2019: The Year of AI Gunjan Bhardwaj, CEO, Innoplexus 4. A Paradigm Shift in the Management of Pharmaceutical Budgets Maarten Van Baelen, Market Access Director, Medicines for Europe 5. Value Added Medicines: Digital Heal...

Being under ever-increasing pressure to compete in a challenging economic and technological environment, pharmaceutical and biotech companies must continually innovate in their R&D programmes to stay ahead of the game. External innovations come in different forms and originate in different places -- from university labs, to privately held venture capital-backed startups and contract research organizations (CROs). Let’s get to reviewing some of the most influential research trends which will be “hot” in 2018 and beyond, and summarize some of the key players driving innovations. Last year BioPharmaTrend summarized several important trends affecting biopharmaceutical industry, namely: an advancement of various aspects of gene editing technologies (mainly, CRISPR/Cas9); a fascinating growth in the area of immuno-oncology (CAR-T cells); an increasing focus on microbiome research; a deepening interest in precision medicine; some important advances in antibiotics discovery;...